Shigematsu Works Co's Days Sales Outstanding for the
six
months ended in Mar. 2026 was 46.06.
Shigematsu Works Co's Days Inventory for the
six
months ended in Mar. 2026 was 137.71.
Shigematsu Works Co's Days Payable for the
six
months ended in Mar. 2026 was 24.22.
Therefore, Shigematsu Works Co's Cash Conversion Cycle (CCC) for the
six
months ended in Mar. 2026 was 159.55.
Shigematsu Works Co (TSE:7980) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Shigematsu Works Co Cash Conversion Cycle Related Terms
Shigematsu Works Co Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Shigematsu Works Co's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7980 vs ISRG, BDX, MDLN: Cash Conversion Cycle Comparison
For the Medical Instruments & Supplies subindustry, Shigematsu Works Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shigematsu Works Co Cash Conversion Cycle vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shigematsu Works Co's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Shigematsu Works Co's Cash Conversion Cycle falls into.
Shigematsu Works Co Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Shigematsu Works Co's Cash Conversion Cycle for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shigematsu Works Co (TSE:7980) has a Cash Conversion Cycle of 159.55 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Shigematsu Works Co and its competitors.
Is Shigematsu Works Co's Cash Conversion Cycle too high?
Shigematsu Works Co's current Cash Conversion Cycle is 159.55. The Medical Devices & Instruments industry median Cash Conversion Cycle is 156.96. Shigematsu Works Co's value of 159.55 is 1.7% above this industry median. Overall, Shigematsu Works Co has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shigematsu Works Co's Cash Conversion Cycle compare to ISRG and BDX?
Shigematsu Works Co's Cash Conversion Cycle of 159.55 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash Conversion Cycle is 156.96. Shigematsu Works Co's value of 159.55 is 1.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Devices & Instruments company?
The median Cash Conversion Cycle among Medical Devices & Instruments companies is 156.96, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shigematsu Works Co's current Cash Conversion Cycle of 159.55 is 1.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Shigematsu Works Co and its competitors. For the Medical Devices & Instruments industry, the median Cash Conversion Cycle is 156.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shigematsu Works Co's current Cash Conversion Cycle is 159.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shigematsu Works Co stock overvalued right now?
Based on GuruFocus' analysis, Shigematsu Works Co (TSE:7980) is currently considered Modestly Undervalued. The stock's GF Value™ is 円946.81, compared to a current price of 円814.00 — trading 14% below its estimated fair value. The current Cash Conversion Cycle is 159.55 and 1.7% above the Medical Devices & Instruments industry median of 156.96. Shigematsu Works Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Shigematsu Works Co (TSE:7980), the current Cash Conversion Cycle is 159.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shigematsu Works Co (TSE:7980) Overvalued in 2026?
Based on GuruFocus' analysis, Shigematsu Works Co stock appears to be undervalued.
The current stock price of 円814.00 is trading 14% below its estimated GF Value™ of 円946.81.
GuruFocus considers Shigematsu Works Co to be Modestly Undervalued.
Key valuation signals for TSE:7980:
Cash Conversion Cycle: 159.55
GF Value™: 円946.81 vs. price of 円814.00 (14% below fair value)
Industry Position: 1.7% above the Medical Devices & Instruments median
No single metric tells the full story. See the TSE:7980 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shigematsu Works Co Ltd is a Japan based company engaged in the safety business. It manufactures personal and respiratory protective devices related to fire and industrial safety, equipment for air purifying, emergency and rescue operations. The company offers products such as gas respirators, chemical cartridge respirators, particulate respirators, self-contained breathing apparatus, powered air-purifying respirators, supplied-air respirators, eye protector, face shields, earmuffs, safety belts, protective clothing, protective gloves, stretchers, oxygen meters and other related products. The products offered by the organization has application in various industries including textile, chemical, automobile, fishery, mining, warehouse and others.
80GF Score
Get the complete analysis for TSE:7980
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7980 has been successfully added to your 
